🚨 New in @NEJM: #APT-Sepsis results are out!
➡️ 32% reduction in maternal infection-related death or severe morbidity
🌍 Consistent across countries
💡 Sustainable, low-cost, scalable
👉 Read the paper t.co/Vx4JGS40wR
#livUni #HRPresearch #MLW_mw #IDIatMak #GlobalHealth #ReproHealth
➡️ 32% reduction in maternal infection-related death or severe morbidity
🌍 Consistent across countries
💡 Sustainable, low-cost, scalable
👉 Read the paper t.co/Vx4JGS40wR
#livUni #HRPresearch #MLW_mw #IDIatMak #GlobalHealth #ReproHealth
https://www.nejm.org/doi/full/10.1056/NEJMoa2512698?query=featured_home
t.co
November 20, 2025 at 8:51 AM
🚨 New in @NEJM: #APT-Sepsis results are out!
➡️ 32% reduction in maternal infection-related death or severe morbidity
🌍 Consistent across countries
💡 Sustainable, low-cost, scalable
👉 Read the paper t.co/Vx4JGS40wR
#livUni #HRPresearch #MLW_mw #IDIatMak #GlobalHealth #ReproHealth
➡️ 32% reduction in maternal infection-related death or severe morbidity
🌍 Consistent across countries
💡 Sustainable, low-cost, scalable
👉 Read the paper t.co/Vx4JGS40wR
#livUni #HRPresearch #MLW_mw #IDIatMak #GlobalHealth #ReproHealth
Get ready for the #APTSepsis results will be released soon, stay tuned for findings. Led by #LiverpoolUniversity & #HRPresearch with partners #MLW_mw & #IDIatMak.
#GlobalHealth #ReproHealth
#GlobalHealth #ReproHealth
November 17, 2025 at 11:18 AM
Get ready for the #APTSepsis results will be released soon, stay tuned for findings. Led by #LiverpoolUniversity & #HRPresearch with partners #MLW_mw & #IDIatMak.
#GlobalHealth #ReproHealth
#GlobalHealth #ReproHealth